Results 191 to 200 of about 450,538 (349)

What is chronic urinary tract infection? A systematic review. [PDF]

BJU Int
Hjelmager JS, Andersen K, Andersen TE, Stærk K.   +3 more
europepmc   +1 more source

Innovative Drugs Approved in China After Registration Classification Reform: Current Status, Disparities, and Challenges

Clinical Pharmacology &Therapeutics, EarlyView.
Since 2016, the China National Medical Products Administration (NMPA) has reformed its drug registration classification rules and defines the innovative drugs as new drugs that have not been marketed domestically and overseas. This study sought to systematically evaluate the characteristics of the innovative drugs approved in China. The cross‐sectional
Xingyue Zhu, Die Xiao
wiley   +1 more source

A case of colorectal cancer with urinary tract infection induced by bayberry pits. [PDF]

World J Emerg Med
Yang S, Li H, Xiao Y.
europepmc   +1 more source

Urinary tract infections treated with single dose of short-acting sulphonamide. [PDF]

, 1979
Gunilla Källenius, Jan Winberg
openalex   +1 more source

Transforming Pharmacovigilance With Pharmacogenomics: Toward Personalized Risk Management

Clinical Pharmacology &Therapeutics, EarlyView.
Pharmacovigilance is a critical component of medication safety. Despite rigorous evaluation of new drugs during clinical trials, some adverse effects might only be identified once pharmaceuticals are used by a larger population for a longer duration.
Claire Spahn, Nanase Toda, Blaine Groat, Omar Aimer, Sara Rogers, Akinyemi Oni‐Orisan, Andrew Monte, Nancy Hakooz, on behalf of the Pharmacogenomics Global Research Network (PGRN) Publications Committee   +8 more
wiley   +1 more source

Application and evaluation of HB&L system in the rapid diagnosis of urinary tract infection. [PDF]

Transl Androl Urol
Huang X, Chang Z, Jiang Y, Chen Y, Wu H, Song Z, Qi D, Cheng ZJ, Sun B.   +8 more
europepmc   +1 more source

Attachment of Escherichia coli to urinary sediment epithelial cells from urinary tract infection-prone and healthy children [PDF]

, 1979
C Svanborg-Edén, Ulf Jodal
openalex   +1 more source

Meta‐analysis of sotagliflozin, a dual sodium‐glucose‐cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes

ESC Heart Failure, Volume 12, Issue 2, Page 968-979, April 2025.
Abstract Sodium‐glucose co‐transporters (SGLTs) mediate sodium and glucose transport across cell membranes. SGLT2 inhibitors have a recognized place within heart failure (HF) guidelines. We evaluated the effect of sotagliflozin on HF and cardiovascular outcomes in participants with type 2 diabetes. Scopus, Medline, Embase and Central were searched from
Maria Anna Bantounou, Panagiotis Sardellis, Josip Plascevic, Ribeya Awaes‐Mahmood, Justyna Kaczmarek, Daniel Black Boada, Rosa Thuemmler, Sam Philip   +7 more
wiley   +1 more source

Evaluation of New Urinary Tract Infection Screening Devices [PDF]

, 1973
William A. Craig, Calvin M. Kunin, Jane DeGroot   +2 more
openalex   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source